The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M03 | Muscle relaxants | |
| 3 | M03A | Muscle relaxants, peripherally acting agents | |
| 4 | M03AB | Choline derivatives |
| Code | Title | |
|---|---|---|
| M03AB01 | Suxamethonium |
| Active Ingredient | Description | |
|---|---|---|
| Suxamethonium |
Suxamethonium is a short-acting depolarising neuromuscular blocking agent. Suxamethonium inhibits neuromuscular transmission by depolarising the motor end plates in skeletal muscle. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ANECTINE Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| ETHICHOLINE Solution for injection | Marketing Authorisation Holder | MPI, US: SPL/PLR | |
| QUELICIN Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |